Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NovoCrops is a Danish biotechnology company specializing in molecular farming, a field that utilizes plants as bioreactors for the production of high-value recombinant proteins. The company's proprietary platform leverages advanced plant genetics to manufacture complex proteins that are traditionally difficult to produce in microbial or mammalian cell cultures. By using plants, NovoCrops aims to provide a more scalable, sustainable, and cost-effective alternative to conventional biomanufacturing methods. Based in Copenhagen and supported by the BioInnovation Institute (BII), the company focuses on optimizing plant-based expression systems for applications in the pharmaceutical and industrial biotechnology sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NovoCrops Biotechnology.